Skip to main content
TipRanks
Go Ultimate75% OFF

Amgen (1AMGN) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

1AMGN Analyst Ratings

Moderate Buy
26Ratings
9Buy16Hold1Sell
Based on 26 analysts giving stock ratings to Amgen in the past 3 months

1AMGN Stock 12 Month Forecast

€420.27▲(6.10% Upside)
Based on 26 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is EUR 420.27 with a high forecast of EUR 494.29 and a low forecast of EUR 316.46. The average price target represents a 6.10% change from the last price of EUR 396.10.
Highest Price Target€494.29Average Price Target€420.27Lowest Price Target€316.46

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:1AMGN
Price TargetArticle
Piper Sandler€416.77→€494.29buy24.79%UpsideReiterated11/19/26
Wells Fargo€419.51hold5.91%UpsideReiterated11/18/26
Barclays€364.79→€392.15hold-1.00%DownsideReiterated11/16/26
Morgan Stanley€373.91hold-5.60%DownsideReiterated11/12/26
Canaccord Genuity€401.27hold1.31%UpsideReiterated11/12/26
Argus Research€419.51→€469.67buy18.57%UpsideReiterated11/12/26
Freedom Capital Markets€410.39→€428.63hold8.21%UpsideDowngraded11/06/26
Citi€369.35→€424.07hold7.06%UpsideReiterated11/05/26
Leerink Partners Analyst forecast on IT:1AMGNUnknown AnalystNot RankedLeerink Partners€360.23→€423.16hold6.83%UpsideReiterated11/05/26
Goldman Sachs€438.66→€488.82buy23.41%UpsideReiterated11/04/26
Bank of America Securities€299.13→€316.46sell-20.11%DownsideReiterated11/04/26
RBC Capital€392.15→€428.63buy8.21%UpsideAssigned11/04/26
J.P. Morgan€319.19→€387.59hold-2.15%DownsideReiterated11/04/26
Bernstein€314.63→€364.79hold-7.90%DownsideAssigned11/04/26
BMO Capital€378.47→€403.10hold1.77%UpsideReiterated11/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PALIPalisade Bio
RZLTRezolute
MDWDMediwound
OVIDOvid Therapeutics
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amgen

3 Months
David Amsellem
David AmsellemPiper Sandler
Success Rate16/22 ratings generated profit
73%
Average Return
+6.03%

Copying David Amsellem's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +6.03% per trade.

1 Year
David Amsellem
David AmsellemPiper Sandler
Success Rate21/22 ratings generated profit
95%
Average Return
+25.66%

Copying David Amsellem's trades and holding each position for 1 Year would result in 95.45% of your transactions generating a profit, with an average return of +25.66% per trade.

2 Years
David Amsellem
David AmsellemPiper Sandler
Success Rate21/22 ratings generated profit
95%
Average Return
+38.24%

Copying David Amsellem's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +38.24% per trade.

1AMGN Analyst Recommendation Trends

050100150200Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 1AMGN
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy1924344136
Hold2226394750
Sell23565
Strong Sell00000
total4353789491

In the current month, 1AMGN has received 36 Buy Ratings, 50 Hold Ratings, and 5 Sell Ratings. 1AMGN average Analyst price target in the past 3 months is 420.27.

1AMGN Financial Forecast

€3€3.75€4.5€5.25€6Q1 2026Q3 2026Q4 2026
High€5.54
Consensus€5.12
Low€4.68

1AMGN Earnings Forecast

Next quarter’s earnings estimate for 1AMGN is EUR 5.12 with a range of EUR 4.68 to EUR 5.54. The previous quarter’s EPS was EUR 5.88. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€7.9B€8.4B€8.9B€9.3B€9.8BQ1 2026Q3 2026Q4 2026
High€9.82B
Consensus€9.54B
Low€9.28B

1AMGN Sales Forecast

Next quarter’s sales forecast for 1AMGN is EUR 9.54B with a range of EUR 9.28B to EUR 9.82B. The previous quarter’s sales results were EUR 9.44B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

1AMGN Stock Forecast FAQ

What is IT:1AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is €420.27.
What is IT:1AMGN’s upside potential, based on the analysts’ average price target?
Amgen has 6.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amgen a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 16 hold ratings and 1 sell ratings.
What is Amgen’s share price target?
The average share price target for Amgen is €420.27. This is based on 26 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €494.29, and the lowest forecast is €316.46. The average share price target represents a 6.10% increase from the current price of €396.1.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 26 Wall Street analysts.
How can I buy shares of Amgen?
To buy shares of IT:1AMGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.